Olfactory, taste dysfunction, SARS-CoV2, COVID-19
Showing 1 - 25 of >10,000
EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH
Completed
- Olfactory and Taste Dysfunction in SARS-CoV2 Infection
- visual analogue scale
-
Ioannina, Epirus, GreeceUniversity General Hospital of Ioannina
Sep 27, 2021
Hyposmia, COVID-19, Parosmia Trial in Trois-Rivières (Smell training)
Recruiting
- Hyposmia
- +4 more
- Smell training
-
Trois-Rivières, Quebec, CanadaUniversité du Québec à Trois-Rivières
May 20, 2022
SARS-CoV-2 Acute Respiratory Disease Trial in Paris (Clinical examination, Blood collection, Olfactory evoked potentials)
Recruiting
- SARS-CoV-2 Acute Respiratory Disease
- Clinical examination
- +6 more
-
Paris, FranceHôpital Lariboisière
Aug 16, 2022
SARS-CoV-2 Trial in Leuven (Sampling of tissue)
Recruiting
- SARS-CoV-2
- Sampling of tissue
-
Leuven, Vlaams-Brabant, BelgiumUZ Leuven
Aug 3, 2022
Anosmia, SARS CoV 2 Infection Trial in London, Wigan, Gorleston-on-Sea (Olfactory Training)
Completed
- Anosmia
- SARS CoV 2 Infection
- Olfactory Training
-
London, England, United Kingdom
- +3 more
Feb 17, 2022
Dogs for the Olfactory Detection of COVID-19
Completed
- COVID-19
- sweat samples and used face mask will be collected
-
Bordeaux, France
- +5 more
May 4, 2023
SARS-CoV-2 Infection, Cognitive Disorder Trial in Paris (Nasopharyngeal swab for RT-PCR SARS-CoV-2)
Recruiting
- SARS-CoV-2 Infection
- Cognitive Disorder
- Nasopharyngeal swab for RT-PCR SARS-CoV-2
-
Paris, France
- +1 more
Jul 18, 2022
COVID-19, Post-COVID-19 Syndrome, Influenza Trial in Kunming (Autonomous Treatment System for Covid-19, Post-Acute Sequelae of
Enrolling by invitation
- COVID-19
- +2 more
- Autonomous Treatment System for Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection and Influenza Based on Machine Learning
-
Kunming, Yunnan, ChinaSheng'Ai Traditional Medicine Hospital
Sep 22, 2023
Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)
Not yet recruiting
- Immunogenicity
- Safety
- Phase II:SWIM816;SARS-Cov-2;
- +3 more
- (no location specified)
Jun 18, 2023
COVID-19 Trial (NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine, Prototype/XBB.1.5 Bivalent Vaccine (5 µg))
Not yet recruiting
- COVID-19
- NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine
- Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
- (no location specified)
Aug 4, 2023
COVID-19 Vaccine, COVID-19 Trial in Bangkok (50 µg Baiya SARS-CoV-2 Vax 2, Placebo)
Not yet recruiting
- COVID-19 Vaccine
- COVID-19
- 50 μg Baiya SARS-CoV-2 Vax 2
- Placebo
-
Bangkok, ThailandQueen Saovabha Memorial Institute
May 23, 2023
SARS-CoV-2 Infection, COVID-19 Recurrent, Cognitive Dysfunction Trial in Vigo, Ourense (COPERIA-REHAB)
Not yet recruiting
- SARS-CoV-2 Infection
- +3 more
- COPERIA-REHAB
-
Vigo, Pontevedra, Spain
- +3 more
Nov 28, 2022
Zinc Deficiency, Sars-CoV-2 Infection Trial in Barcelona (Zinc Acetate)
Completed
- Zinc Deficiency
- Sars-CoV-2 Infection
- Zinc Acetate
-
Barcelona, SpainHospital del Mar
Mar 18, 2023
The ACDC Study Assessing Cognitive Deterioration in COVID-19
Recruiting
- SARS-CoV-2 Infection
- +2 more
- Magnetic Resonance Imaging
-
Aberdeen, Grampian, United KingdomAberdeen Royal Infirmary
May 10, 2023
Security Efficacy COVID-19 Vaccination
Completed
- Autoimmune State
- SARS-CoV-2 Infection
- Blood sampling
-
Milan, ItalyIstituto Auxologico Italiano IRCCS
Feb 23, 2023
Covid19 Trial in Cypress (VXA-CoV2-1)
Completed
- Covid19
- VXA-CoV2-1
-
Cypress, CaliforniaWCCT
Jan 17, 2023
a Randomized Double-blind Study, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), PHYTOTHERAPIE Trial in Sahloul
Completed
- a Randomized Double-blind Study
- +2 more
-
Sahloul, Sousse, TunisiaRiadh Boukef
Jan 2, 2023
SARS-CoV-2 Infection, COVID-19, Coronavirus Trial in Marseille, Nîmes (eBAM Cov Testing)
Not yet recruiting
- SARS-CoV-2 Infection
- +2 more
- eBAM Cov Testing
-
Marseille, France
- +1 more
Oct 23, 2023
COVID-19 Transmission and Morbidity in Malawi
Recruiting
- SARS CoV 2 Infection
- SARS CoV 2 Vaccination
-
Boston, Massachusetts
- +1 more
Aug 6, 2023
Awake Prone Positioning in COVID-19 ICU Patients
Not yet recruiting
- SARS-CoV 2 Pneumonia
- quality of life questionnaire
-
Tours, Franceuniversity hospital Tours
Oct 10, 2023
Covid19, SARS-CoV Infection Trial in Rochester (Fisetin, Placebo)
Enrolling by invitation
- Covid19
- SARS-CoV Infection
- Fisetin
- Placebo
-
Rochester, MinnesotaMayo Clinic
Jan 23, 2023
Vitamin A and E Deficiency With Severity of SARS-COV-2 Disease:
Completed
- COVID-19
-
Cairo, None Selected, Egyptbalsam Sherif Fahmy
Jul 12, 2023
A Study of the Effectiveness of Moderna COVID-19 Vaccine
Recruiting
- SARS-CoV-2
- COVID-19
- mRNA-1273
-
Pasadena, CaliforniaKaiser Permanente Southern California
Jul 5, 2023
SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive
Not yet recruiting
- COVID-19
- +5 more
- imPulse™ Una infrasound-to-ultrasound e-stethoscope
- (no location specified)
Mar 9, 2023
COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients
Completed
- Multiple Sclerosis
- Covid19
-
New York, New YorkNYU Langone Health
Nov 2, 2022